SIRT5 and hepatocellular carcinoma: We recently reported that low SIRT5 expression is associated with unfavorable prognosis for hepatocellular carcinoma cancer (HCC) patients, although whether SIRT5 downregulation contributes to HCC development remains to be addressed [58].